Literature DB >> 11960348

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia.

M S Jabber Al-Obaidi1, M Martineau, C F Bennett, I M Franklin, A H Goldstone, L Harewood, G R Jalali, H G Prentice, S M Richards, K Roberts, C J Harrison.   

Abstract

Dual-color interphase fluorescence in situ hybridization (FISH) with ETV6 and AML1 probes was used for the first time on a series of 159 adult patients with acute lymphoblastic leukemia (ALL), for detection of the t(12;21)(p13;q22) translocation. Seven patients (4.4%) were found, with 50-100% of positive cells, of whom one of two tested, proved negative for the fusion product by RT-PCR. Two of them, aged 43 and 50 years, are the oldest patients so far confirmed to have the translocation. Three who relapsed at 10, 11 and 24 months, suggest that adults may not enjoy the good short-term prognosis reported for t(12;21)-positive children. Thirty-one-negative cases had signal numbers differing from the two expected for each gene. In 15 cases these results were consistent with the karyotype. In nine cases with uninformative cytogenetics, the numbers were consistent with those for centromeres and indicated a hidden aneuploidy. Loss of ETV6 genes in two cases and AML1 amplification in three others were not suspected from the cytogenetics. In conclusion, FISH proved to be reliable in defining ETV6/AML1 positivity in this group of patients as well as providing valuable insights into negative cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960348     DOI: 10.1038/sj.leu.2402435

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  Guidance for fluorescence in situ hybridization testing in hematologic disorders.

Authors:  Daynna J Wolff; Adam Bagg; Linda D Cooley; Gordon W Dewald; Betsy A Hirsch; Peter B Jacky; Kathleen W Rao; P Nagesh Rao
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  Secretory carcinoma - impact of translocation and gene fusions on salivary gland tumor.

Authors:  Ryoko Inaki; Masanobu Abe; Liang Zong; Takahiro Abe; Aya Shinozaki-Ushiku; Tetsuo Ushiku; Kazuto Hoshi
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

Review 3.  The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.

Authors:  Lorena Quirico; Francesca Orso
Journal:  Cancer Drug Resist       Date:  2020-02-21

4.  Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.

Authors:  Thomas Burmeister; Nicola Gökbuget; Stefan Schwartz; Lars Fischer; Daniela Hubert; Annette Sindram; Dieter Hoelzer; Eckhard Thiel
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

Review 5.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia.

Authors:  Krzysztof Mrózek; David P Harper; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

Review 6.  New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.

Authors:  Anthony V Moorman
Journal:  Haematologica       Date:  2016-04       Impact factor: 9.941

Review 7.  Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment.

Authors:  Tao Xu; Hongxiang Wang; Xiaoquan Huang; Weiqing Li; Qilin Huang; Yong Yan; Juxiang Chen
Journal:  Transl Oncol       Date:  2018-03-20       Impact factor: 4.243

8.  Cytogenetic findings of patients with acute lymphoblastic leukemia in fars province.

Authors:  Akbar Safaei; Jahanbanoo Shahryari; Mohamad Reza Farzaneh; Narjes Tabibi; Marzieh Hosseini
Journal:  Iran J Med Sci       Date:  2013-12

9.  Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.

Authors:  Monica Messina; Sabina Chiaretti; Jiguang Wang; Anna Lucia Fedullo; Nadia Peragine; Valentina Gianfelici; Alfonso Piciocchi; Fulvia Brugnoletti; Filomena Di Giacomo; Simona Pauselli; Antony B Holmes; Maria Cristina Puzzolo; Giulia Ceglie; Valerio Apicella; Marco Mancini; Geertruy Te Kronnie; Anna Maria Testi; Antonella Vitale; Marco Vignetti; Anna Guarini; Raul Rabadan; Robin Foà
Journal:  Oncotarget       Date:  2016-03-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.